Results 1 to 10 of about 1,037,588 (238)
Canadian Journal of Gastroenterology and Hepatology, 2022 Objectives. We assessed the potential of glial cell line-derived neurotrophic factor (GDNF) as a useful biomarker to predict cirrhosis in chronic hepatitis B (CHB) patients. Methods.
Guangyue Yang +17 more
doaj +1 more source
Analytical Cellular Pathology, 2022 Nowadays, microRNA-375 (miR-375) has been implicated in many types of cancers, including hepatocellular carcinoma (HCC), and the functions of miRNAs encapsulated by extracellular vesicles (EV) in HCC progression have also been extensively investigated ...
Zhaoxia Yu +5 more
doaj +1 more source
Characterization of Frequency-Dependent Material Properties of Human Liver and its Pathologies Using an Impact Hammer [PDF]
Medical Image Analysis, 2011, Vol. 15, No.1, pp. 45-52, 2021 The current methods for characterization of frequency-dependent material properties of human liver are very limited. In fact, there is almost no data available in the literature showing the variation in dynamic elastic modulus of healthy or diseased human liver as a function of excitation frequency.
arxiv +1 more source
Emergency Medicine International, 2022 Objectives. To investigate the effects of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) on liver function and immune function in patients with hepatocellular carcinoma (HCC). Methods.
Yan Zhou +6 more
doaj +1 more source
Sphingomyelinases and Liver Diseases [PDF]
Biomolecules, 2020 Sphingolipids (SLs) are critical components of membrane bilayers that play a crucial role in their physico-chemical properties. Ceramide is the prototype and most studied SL due to its role as a second messenger in the regulation of multiple signaling pathways and cellular processes.
Naroa Insausti-Urkia +3 more
openaire +4 more sources
BMC Gastroenterology, 2023 Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide, and is characterized by insidious onset, rapid progression, and poor prognosis. Immunotherapy is a first-line treatment for advanced HCC.
Rui Hu +13 more
doaj +1 more source
Scientific Reports, 2023 Peripheral blood mononuclear cell (PBMC) genes reflect the host immune status and could be suitable for evaluating the prognosis of patients with hepatocellular carcinoma (HCC), for which a reliable biomarker is unavailable and the host immune responses ...
Jing Li +10 more
doaj +1 more source
Canadian Journal of Gastroenterology and Hepatology, 1999 A mild to moderate iron excess is found in patients with liver diseases apparently unrelated to genetic hemochromatosis. Iron appears to affect the natural history of hepatitis C virus‐related chronic liver diseases, alcoholic liver disease and nonalcoholic steatohepatitis by leading to a more severe fibrosis and thus aiding the evolution to cirrhosis ...
S.R. Fargion +3 more
openaire +6 more sources
Precision Medical Sciences, 2022 Abnormal SORT1 expression has been reported in various cancers. However, the expression and function of SORT1 in hepatocellular carcinoma (HCC) remain to be explored.
Minjie Lin +5 more
doaj +1 more source